BAX

Baxter International Inc

BAX, USA

Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products and Therapies, Healthcare Systems and Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; administrative sets; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space comprising operating room integration technologies, precision positioning devices, and other accessories. The company also provides specialty injectable pharmaceuticals, inhaled anesthetics, and drug compounding services. Its products are used in hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, kidney dialysis centers, and patients at home under physician supervision. The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers. It has an agreement with Celerity Pharmaceuticals, LLC to develop acute care generic injectable premix and oncolytic products. The company operates in Eastern Europe, the Middle East, Africa, Latin America, Asia, Western Europe, Canada, Japan, Australia, and New Zealand. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

https://www.baxter.com

Stock Price

$0.00

0%

decrease compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
BAX
stock
BAX

Baxter International: Transition Year With No Immediate Catalysts (NYSE:BAX) Seeking Alpha

Read more →
BAX
stock
BAX

How Recent Analyst Shifts Are Rewriting The Baxter International (BAX) Investment Story Yahoo Finance

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

HOLD

Target Price:

$23.1333

Analyst Picks

Strong Buy

4

Buy

2

Hold

11

Sell

0

Strong Sell

1

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Book Ratio (P/B)

-

Low

1.41

Low 1

High 3

Return on Equity (ROE)

-

Very Low

-0.64 %

Low 5%

High 25%

Return on Assets (ROA)

-

Very Low

-0.22 %

Low 2%

High 10%

Free Cash Flow - Revenue % (FCF)

-

Very Low

4.44 %

Low 5%

High 15%

Debt to Equity

-

Very Low

1.91

Low 1

High 0.3

Investors

* Institutions hold a combined 104.51% of the total shares of Baxter International Inc

1.

BlackRock Inc

(13.1864%)

since

2025/06/30

2.

Vanguard Group Inc

(12.1082%)

since

2025/06/30

3.

Dodge & Cox

(10.1479%)

since

2025/06/30

4.

Pzena Investment Management, LLC

(7.6587%)

since

2025/06/30

5.

Dodge & Cox Stock I

(6.8674%)

since

2025/06/30

6.

T. Rowe Price Associates, Inc.

(4.276%)

since

2025/06/30

7.

State Street Corp

(4.2711%)

since

2025/06/30

8.

Vanguard Total Stock Mkt Idx Inv

(3.1469%)

since

2025/07/31

9.

Bank of New York Mellon Corp

(2.5678%)

since

2025/06/30

10.

BlackRock Equity Dividend Instl

(2.5448%)

since

2025/07/31

11.

Geode Capital Management, LLC

(2.5083%)

since

2025/06/30

12.

Vanguard 500 Index Investor

(2.4742%)

since

2025/07/31

13.

Vanguard Mid Cap Index Institutional

(2.2286%)

since

2025/07/31

14.

Harris Associates L.P.

(1.8201%)

since

2025/06/30

15.

Amvescap Plc.

(1.7334%)

since

2025/06/30

16.

Pzena Large Cap Value

(1.669%)

since

2025/08/31

17.

T. Rowe Price US Mid-Cap Value Equity

(1.5296%)

since

2025/06/30

18.

T. Rowe Price Mid-Cap Value

(1.5273%)

since

2025/07/31

19.

Ameriprise Financial Inc

(1.4872%)

since

2025/06/30

20.

Vanguard Windsor Investor Shares

(1.3561%)

since

2025/06/30

21.

Fidelity 500 Index

(1.2665%)

since

2025/07/31

22.

Oakmark Investor

(1.2597%)

since

2025/06/30

23.

State Farm Mutual Automobile Ins Co

(1.212%)

since

2025/06/30

24.

SPDR® S&P 500® ETF

(1.2044%)

since

2025/08/31

25.

iShares Core S&P 500 ETF

(1.2023%)

since

2025/08/31

26.

Bank of America Corp

(1.0938%)

since

2025/06/30

27.

NORGES BANK

(1.0648%)

since

2025/06/30

28.

UBS Group AG

(1.018%)

since

2025/06/30

29.

Morgan Stanley - Brokerage Accounts

(1.0082%)

since

2025/06/30

30.

Artisan Partners Limited Partnership

(0.9739%)

since

2025/06/30

31.

Franklin Resources Inc

(0.936%)

since

2025/06/30

32.

LSV Asset Management

(0.9356%)

since

2025/06/30

33.

Northern Trust Corp

(0.9267%)

since

2025/06/30

34.

Vanguard Value Index Inv

(0.8854%)

since

2025/07/31

35.

Invesco S&P 500® Equal Weight ETF

(0.8768%)

since

2025/08/29

36.

T. Rowe Price U.S. Mid-Cap Val Eq Tr-D

(0.827%)

since

2025/06/30

37.

Vanguard Selected Value Inv

(0.7183%)

since

2025/06/30

38.

The Health Care Select Sector SPDR® ETF

(0.6822%)

since

2025/08/31

39.

Bridge Builder Large Cap Value

(0.6668%)

since

2025/08/31

40.

Franklin Mutual Shares Z

(0.6446%)

since

2025/07/31

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

2025-12-31

EPS Estimate

0.547

Latest Release

Date

2025-09-30

EPS Actual

0.69

EPS Estimate

0.6

EPS Difference

0.09

Surprise Percent

15%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Potential Value Candidate(5)
Defensive
Moderately Defensive(5.5)
Dividend
Weak Dividend Profile(3)
Economic Moat
Some Competitive Advantage(5.3)
GARP
Not Attractive for GARP(3)
Growth
Weak Growth Prospect(3)
Momentum
No Momentum(3)
Net Net
Not Undervalued (Net-Net)(2.5)
Quality
Moderate Quality(3.5)
Value
Fair Value(4)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.